Thyroid Nodule Management: Clinical, Ultrasound and Cytopathological Parameters for Predicting Malignancy

Overview

Journal Clinics (Sao Paulo)

Publisher Elsevier

Specialty General Medicine

Date 2012 Sep 6

PMID 22948464

Citations 15

Authors

Frederico F R Maia

Denise Engelbrecht Zantut-Wittmann

Affiliations

Soon will be listed here.

Abstract

Although fine-needle aspiration cytology is considered to be the reference method for evaluating thyroid nodules, the results are inaccurate in approximately 10-30% of cases. Several studies have attempted to predict the risk of malignancy in thyroid nodules based on age, nodularity, thyrotropin values, thyroid autoimmune disease, hot/cold nodule status, and ultrasound parameters. However, no consensus has been found, and none of these parameters has significantly affected patient management. The management of indeterminate thyroid nodules and re-biopsies of nodules with initially benign cytological results remain important and controversial topics of discussion. The Bethesda cytological system and several studies on the use of molecular markers to predict malignancy from cytological samples of thyroid nodules need further clarification. More in-depth discussions among and continuous education of the specialists involved in treating thyroid disease are necessary to improve the management of these patients. This review aims to examine the clinical, laboratory, ultrasound, and scintigraphic parameters that can be used for thyroid nodule management.

Citing Articles

Papillary Thyroid Cancer in a Patient With Graves' Disease and Hyperfunctioning (Hot) Thyroid Nodules: An Unexpected Presentation.

Jamal F, Hakobyan N, Siddiqui S Cureus. 2024; 16(7):e64373.

PMID: 39130909 PMC: 11316937. DOI: 10.7759/cureus.64373.

Correlation between genetic alterations and clinicopathological features of papillary thyroid carcinomas.

Shang S, Yang H, Chen M, Wu J, Shi X, Li X J Int Med Res. 2024; 52(3):3000605241233166.

PMID: 38456650 PMC: 10924567. DOI: 10.1177/03000605241233166.

Risk Stratification of Differentiated Thyroid Cancer at King Abdullah Specialized Children's Hospital Endocrinology Clinic in Riyadh, Saudi Arabia.

Al-Dahash R, Alsohaim A, Almutairi Z, Almutairi K, Alharbi A, Alayed S Cureus. 2024; 15(12):e51372.

PMID: 38161535 PMC: 10757736. DOI: 10.7759/cureus.51372.

Preoperative Thyroid-Stimulating Hormone Levels and Risk of Thyroid Cancer in Post-thyroidectomy Patients for Thyroid Nodules: A Study From a Tertiary Hospital in Western Saudi Arabia.

Al-Hakami H, Altayyeb J, Alsharif S, Alshareef M, I Awad B, Al-Garni M Cureus. 2023; 15(10):e47622.

PMID: 38022328 PMC: 10667624. DOI: 10.7759/cureus.47622.

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics.

Liu W, Zhu J, Wu Z, Yin Y, Wu Q, Wu Y Front Oncol. 2023; 13:1269751.

PMID: 37795451 PMC: 10546062. DOI: 10.3389/fonc.2023.1269751.

References

Fiore E, Rago T, Provenzale M, Scutari M, Ugolini C, Basolo F . L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer. 2010; 17(1):231-9. DOI: 10.1677/ERC-09-0251. View

Davidov T, Trooskin S, Shanker B, Yip D, Eng O, Crystal J . Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery. 2010; 148(6):1294-9. DOI: 10.1016/j.surg.2010.09.029. View

Choi S, Han K, Yoon J, Moon H, Son E, Youk J . Factors affecting inadequate sampling of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules. Clin Endocrinol (Oxf). 2011; 74(6):776-82. DOI: 10.1111/j.1365-2265.2011.04011.x. View

Cerutti J, Latini F, Nakabashi C, Delcelo R, Andrade V, Amadei M . Diagnosis of suspicious thyroid nodules using four protein biomarkers. Clin Cancer Res. 2006; 12(11 Pt 1):3311-8. DOI: 10.1158/1078-0432.CCR-05-2226. View

Baier N, Hahn P, Gervais D, Samir A, Halpern E, Mueller P . Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol. 2009; 193(4):1175-9. DOI: 10.2214/AJR.08.1840. View

Maia F, Matos P, Pavin E, Vassallo J, Zantut-Wittmann D . Value of repeat ultrasound-guided fine-needle aspiration in thyroid nodule with a first benign cytologic result: impact of ultrasound to predict malignancy. Endocrine. 2011; 40(2):290-6. DOI: 10.1007/s12020-011-9467-0. View

Giorgadze T, Rossi E, Fadda G, Gupta P, LiVolsi V, Baloch Z . Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?. Diagn Cytopathol. 2004; 31(5):307-12. DOI: 10.1002/dc.20132. View

STUDER H, Derwahl M . Mechanisms of nonneoplastic endocrine hyperplasia--a changing concept: a review focused on the thyroid gland. Endocr Rev. 1995; 16(4):411-26. DOI: 10.1210/edrv-16-4-411. View

Hegedus L . Clinical practice. The thyroid nodule. N Engl J Med. 2004; 351(17):1764-71. DOI: 10.1056/NEJMcp031436. View

10.

Baloch Z, LiVolsi V, Jain P, Jain R, Aljada I, Mandel S . Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules. Diagn Cytopathol. 2003; 29(4):203-6. DOI: 10.1002/dc.10361. View

11.

Choi Y, Yun J, Kim D . Clinical and ultrasound features of cytology diagnosed follicular neoplasm. Endocr J. 2009; 56(3):383-9. DOI: 10.1507/endocrj.k08e-310. View

12.

Fadda G, Rossi E, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F . Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol. 2011; 165(3):447-53. DOI: 10.1530/EJE-11-0181. View

13.

Maia A, Ward L, Carvalho G, Graf H, Maciel R, Maciel L . [Thyroid nodules and differentiated thyroid cancer: Brazilian consensus]. Arq Bras Endocrinol Metabol. 2007; 51(5):867-93. DOI: 10.1590/s0004-27302007000500027. View

14.

Elte J, Bussemaker J, Haak A . The natural history of euthyroid multinodular goitre. Postgrad Med J. 1990; 66(773):186-90. PMC: 2429462. DOI: 10.1136/pgmj.66.773.186. View

15.

Derwahl M . TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas--a note of caution. J Clin Endocrinol Metab. 1996; 81(8):2783-5. DOI: 10.1210/jcem.81.8.8768829. View

16.

Alexander E, Hurwitz S, Heering J, Benson C, Frates M, Doubilet P . Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003; 138(4):315-8. DOI: 10.7326/0003-4819-138-4-200302180-00010. View

17.

Pennelli G, Mian C, Pelizzo M, Naccamulli D, Piotto A, Girelli M . Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study. Acta Cytol. 2009; 53(5):533-9. DOI: 10.1159/000325381. View

18.

Carpi A, Ferrari E, Toni M, Sagripanti A, Nicolini A, Di Coscio G . Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a long-term study. J Clin Oncol. 1996; 14(5):1704-12. DOI: 10.1200/JCO.1996.14.5.1704. View

19.

Kihara M, Ito Y, Hirokawa M, Masuoka H, Yabuta T, Tomoda C . Role of ultrasonography in patients with cytologically follicular thyroid tumor. Auris Nasus Larynx. 2011; 38(4):508-11. DOI: 10.1016/j.anl.2010.09.011. View

20.

Davies L, Welch H . Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295(18):2164-7. DOI: 10.1001/jama.295.18.2164. View